Stratos Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $334K | Sell |
13,853
-2,249
| -14% | -$58.8K | 0.01% | 306 |
|
|
2026
Q1 | $452K | Buy |
16,102
+1,136
| +8% | +$30.2K | 0.02% | 263 |
|
|
2025
Q4 | $373K | Sell |
14,966
-926
| -6% | -$23.4K | 0.01% | 267 |
|
|
2025
Q3 | $405K | Sell |
15,892
-435
| -3% | -$10.7K | 0.02% | 267 |
|
|
2025
Q2 | $396K | Sell |
16,327
-455
| -3% | -$10.6K | 0.02% | 277 |
|
|
2025
Q1 | $425K | Sell |
16,782
-3,648
| -18% | -$95.5K | 0.02% | 221 |
|
|
2024
Q4 | $542K | Buy |
20,430
+5,502
| +37% | +$149K | 0.03% | 169 |
|
|
2024
Q3 | $432K | Buy |
14,928
+2,013
| +16% | +$58.7K | 0.03% | 170 |
|
|
2024
Q2 | $361K | Sell |
12,915
-2,479
| -16% | -$68.3K | 0.03% | 166 |
|
|
2024
Q1 | $427K | Sell |
15,394
-158,715
| -91% | -$4.4M | 0.04% | 147 |
|
|
2023
Q4 | $5.01M | Buy |
174,109
+14,397
| +9% | +$435K | 0.59% | 51 |
|
|
2023
Q3 | $5.3M | Buy |
159,712
+19,756
| +14% | +$699K | 0.79% | 38 |
|
|
2023
Q2 | $5.13M | Buy |
139,956
+3,732
| +3% | +$145K | 0.79% | 38 |
|
|
2023
Q1 | $5.56M | Sell |
136,224
-11,250
| -8% | -$486K | 0.94% | 29 |
|
|
2022
Q4 | $7.56M | Buy |
147,474
+1,010
| +0.7% | +$48.4K | 1.35% | 23 |
|
|
2022
Q3 | $6.41M | Sell |
146,464
-9,830
| -6% | -$478K | 1.3% | 23 |
|
|
2022
Q2 | $8.2M | Buy |
156,294
+3,437
| +2% | +$175K | 1.55% | 21 |
|
|
2022
Q1 | $7.91M | Sell |
152,857
-10,645
| -7% | -$552K | 1.31% | 24 |
|
|
2021
Q4 | $9.65M | Buy |
163,502
+7,538
| +5% | +$373K | 1.52% | 18 |
|
|
2021
Q3 | $6.71M | Buy |
155,964
+23,197
| +17% | +$1.03M | 1.17% | 24 |
|
|
2021
Q2 | $5.2M | Buy |
132,767
+12,371
| +10% | +$481K | 1.43% | 20 |
|
|
2021
Q1 | $4.36M | Sell |
120,396
-5,357
| -4% | -$190K | 1.38% | 20 |
|
|
2020
Q4 | $4.63M | Buy |
125,753
+5,333
| +4% | +$196K | 1.46% | 21 |
|
|
2020
Q3 | $4.19M | Buy |
120,420
+8,697
| +8% | +$305K | 1.52% | 18 |
|
|
2020
Q2 | $3.47M | Buy |
111,723
+17,454
| +19% | +$593K | 1.47% | 18 |
|
|
2020
Q1 | $2.92M | Buy |
94,269
+26,318
| +39% | +$897K | 1.55% | 17 |
|
|
2019
Q4 | $2.53M | Buy |
67,951
+16,711
| +33% | +$595K | 1.17% | 19 |
|
|
2019
Q3 | $1.75M | Buy |
51,240
+7,837
| +18% | +$285K | 0.99% | 23 |
|
|
2019
Q2 | $1.78M | Buy |
43,403
+10,831
| +33% | +$430K | 1.13% | 19 |
|
|
2019
Q1 | $1.31M | Buy |
+32,572
| New | +$1.3M | 1.03% | 20 |
|
Other funds holding PFE
Stratos Investment Management's PFE Position: Q2 2026 in Review
Stratos Investment Management reduced its Pfizer (PFE) stake by 14% in Q2 2026, selling an estimated $58.8K and leaving 13,853 shares worth $334K. The position accounts for 0.01% of the portfolio, ranked #306.
Stratos Investment Management first reported a position in PFE in Q1 2019 and has held it in 30 quarters since. The position peaked at $9.65M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Stratos Investment Management held 13,853 shares of Pfizer worth $334K as of Q2 2026.
- Stratos Investment Management sold 2,249 Pfizer shares in Q2 2026, an estimated $58.8K.
- Pfizer made up 0.01% of Stratos Investment Management's portfolio in Q2 2026, its #306 holding.
- Stratos Investment Management first reported a position in Pfizer in Q1 2019 and has held it in 30 quarters since.
- Stratos Investment Management's Pfizer position peaked at $9.65M in Q4 2021.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Stratos Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.